OncoCyte Corp. | Mutual Funds
Mutual Funds that own OncoCyte Corp.
Vanguard Total Stock Market Index Fund
318,793
0.78%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
130,000
0.32%
0
0.08%
12/31/2017
Vanguard Extended Market Index Fund
62,772
0.15%
10,300
0%
07/31/2018
British & American Investment Trust Plc (Top 20 Holdings)
30,545
0.08%
-11,671
0.21%
12/31/2017
Vanguard Institutional Total Stock Market Index Fund
14,374
0.04%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
11,637
0.03%
0
0%
07/31/2018
Fidelity Spartan Small Cap Index Fund
8,344
0.02%
1,289
0%
04/30/2018
CREF Stock Account
7,393
0.02%
0
0%
03/31/2018
4,744
0.01%
0
0.04%
09/05/2018
TIAA-CREF Small Cap Blend Index Fund
4,250
0.01%
0
0%
05/31/2018
| Address |
1010 Atlantic Avenue
Alameda California 94501
United States
|
|
Employees
|
- |
| Website |
http://www.oncocyte.com |
| Updated |
07/08/2019 |
| OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA. |
